← Back to People
Brandon White is a co-founder and CEO at Axiom Bio developing reasoning agents for drug predictions.
4
Mentions
4
Articles
3
Outlets
Apr 2026 — May 2026
Coverage
Positive
Sentiment
Companies Covered
Appears In
Sentiment Distribution
Based on 4 scored articles
Positive 75%Negative 25%
Appears Alongside
Articles
Most recent firstMentioned In
Referenced in coverage
GPT-5.5 Outperforms, Hallucinates
info.deeplearning.aicautiousMay 1, 2026
“Reports that GPT-5.5 delivered significant accuracy gains on drug discovery evals using their biochemical datasets.”
OpenAI released GPT-5.5
OpenAIpositiveApr 28, 2026
“Co-Founder and CEO at Axiom Bio who highlighted GPT-5.5's ability to predict drug outcomes and deliver accuracy gains on drug discovery evaluations.”
OpenAI releases GPT-5.5 with faster speed and stronger agentic coding
OpenAIpositiveApr 24, 2026
“Praised GPT-5.5 for delivering significant accuracy gains on drug discovery evals when applied to biochemical datasets.”
Next.js React2Shell: 766 Hosts Breached, Credentials Harvested at Scale
The Hacker NewsnegativeApr 3, 2026
“Co-authored analysis of UAT-10608 threat cluster exploiting CVE-2025-55182 to harvest credentials from 766 hosts.”